Advisory Board

 

We thank our Advisory Board members for their contribution to the agenda in 2017, and look forward to working together to make 2018 even more successful.

 

Professor Michael Linden, Former VP Gene Therapy & Head, GMI, Pfizer

Professor Michael Linden
Former VP Gene Therapy & Head, GMI
Pfizer

Dr Carlo Incerti, SVP, Head of Global Medical Affairs, CMO, Genzyme, A Sanofi Company

Dr Carlo Incerti 
SVP, Head of Global Medical Affairs, CMO
Genzyme, A Sanofi Company

Yann Le Cam, Chief Executive Officer, EURORDIS

Yann Le Cam
Chief Executive Officer
EURORDIS

Dr Ségolène Aymé, Founder of Orphanet, Emeritus Research Director, INSERM

Dr Ségolène Aymé
Founder of Orphanet, Emeritus Research Director
INSERM

 
 

Dr Bruno Sepodes, Chair of COMP, EMA

Dr Bruno Sepodes
Chair of COMP
EMA

Alastair Kent, Director, Genetic Alliance UK

Alastair Kent
Director
Genetic Alliance UK

Sheela Upadhyaya, Assoc. Director Highly Specialised Technologies, National Institute For Health and Care Excellence

Sheela Upadhyaya
Assoc. Director Highly Specialised Technologies
National Institute For Health and Care Excellence

 

 

DOWNLOAD PROSPECTUS

Get Involved At World Orphan Drug Congress 2018

 

To Sponsor Or Exhibit

 
 

Andrew Mears
andrew.mears@terrapinn.com
t/ +44 20 7092 1228

 

 

 

To Speak

 
 

Wing-Yun Cheung
wing-yun.cheung@terrapinn.com
t/ +44 20 7092 1172

 

 

 

To Register

 
 

Issa Mauthoor
issa.mauthoor@terrapinn.com
t/ +44 20 7092 1257